PAPER Yang Y, Wang Y, Jiang X, Mi J, Ge D, Tong Y, Zhu Y
SEARCH RESULTS
339206 RESULTS
PAPER Tahir M, Kang MH, Park TJ, Ali J, Choe K, Park JS, Kim MO
Multifaceted neuroprotective approach of Trolox in Alzheimer's disease mouse model: targeting Aβ pathology, neuroinflammation, oxidative stress, and synaptic dysfunction.
Front Cell Neurosci. 2024;18:1453038. Epub 2024 Sep 17 PubMed.PAPER Panizza E, Cerione RA
An interpretable deep learning framework identifies proteomic drivers of Alzheimer's disease.
Front Cell Dev Biol. 2024;12:1379984. Epub 2024 Sep 17 PubMed.PAPER Huang X, Wang Y, Xiang Y, Zhao Y, Pan H, Liu Z, Xu Q, Sun Q, Tan J, Yan X, Li J, Tang B, Guo J
Genetic Analysis of Neurite Outgrowth Inhibitor-Associated Genes in Parkinson's Disease: A Cross-Sectional Cohort Study.
CNS Neurosci Ther. 2024 Oct;30(10):e70070. PubMed.PAPER Xiong B, Song Z, Wang L, Zhang A, Zhou Y, Zheng N, Wei Y, Chen Y, Sun H
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?
ACS Chem Neurosci. 2024 Oct 2;15(19):3434-3436. Epub 2024 Sep 18 PubMed.PAPER Subhan I, Siddique YH
Modeling of Parkinson's Disease in Different Models.
CNS Neurol Disord Drug Targets. 2024 Oct 1; PubMed.PAPER Granholm AC, Larsson L, Öhman F, Zetterberg H, Hansson O, Eriksdotter M, Kern S, Nordberg A
[Dementia in Down syndrome].
Lakartidningen. 2024 Sep 30;121 PubMed.PAPER Koirala S, Sharma H, Chew YL, Konopka A
SimplySmart_v1, a new tool for the analysis of DNA damage optimized in primary neuronal cultures.
BMC Bioinformatics. 2024 Oct 1;25(1):318. PubMed.PAPER Trabado-Fernández A, García-Colomo A, Cuadrado-Soto E, Peral-Suárez Á, Salas-González MD, Lorenzo-Mora AM, Aparicio A, Delgado-Losada ML, Maestú-Unturbe F, López-Sobaler AM
Association of a DASH diet and magnetoencephalography in dementia-free adults with different risk levels of Alzheimer's disease.
Geroscience. 2024 Oct 1; PubMed.PAPER Ling Y, Yuan S, Huang X, Tan S, Cheng H, Li L, Li S, Huang L, Xu A, Lyu J
Association between probable sarcopenia and dementia risk: a prospective cohort study with mediation analysis.
Transl Psychiatry. 2024 Oct 1;14(1):398. PubMed.PAPER Ghanbarabadi M, Iranshahi M, Amoueian S, Mehri S, Motamedshariaty VS, Mohajeri SA
Retraction notice to "Neuroprotective and memory enhancing effects of auraptene in a rat model of vascular dementia: Experimental study and histopathological evaluation" [Neurosci. Lett. 623 (2016) 13-21].
Neurosci Lett. 2024 Oct 1;:138002. PubMed. Retracted paper.PAPER Baduini IR, Castro Vildosola JE, Kavehmoghaddam S, Kiliç F, Nadeem SA, Nizama JJ, Rowand MA, Annapureddy D, Bryan CA, Do LH, Hsiao S, Jonnalagadda SA, Kasturi A, Mandava N, Muppavaram S, Ramirez B, Siner A, Suoto CN, Tamajal N, Scoma ER, Da Costa RT, Solesio ME
Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection.
Pharmacol Res. 2024 Sep 30;209:107439. PubMed.PAPER Kunach P, Vaquer-Alicea J, Smith MS, Monistrol J, Hopewell R, Moquin L, Therriault J, Tissot C, Rahmouni N, Massarweh G, Soucy JP, Guiot MC, Shoichet BK, Rosa-Neto P, Diamond MI, Shahmoradian SH
Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240.
Nat Commun. 2024 Oct 1;15(1):8497. PubMed.Pan Zheng
OncoC4, Inc.Rockville, United States
Julian Castano
Colombia
Current Filters
No filters selected